Skip to main content

atrial fibrillation

By Adam Ang | 09:28 pm | September 17, 2024
Cardio Intelligence is now testing its latest AI for detecting paroxysmal atrial fibrillation. 
By Jessica Hagen | 01:05 pm | May 06, 2024
The Agency has qualified Apple's atrial fibrillation history feature as a medical device development tool, allowing it to be used in clinical trials.
By Emily Olsen | 11:16 am | September 16, 2022
The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.
By Emily Olsen | 01:08 pm | July 22, 2022
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
By Adam Ang | 12:37 am | January 12, 2022
The consumer app enables users to monitor their own heart rhythm round the clock.
By Mallory Hackett | 01:11 pm | September 29, 2021
The most common arrhythmias detected were premature atrial contractions, premature ventricular contractions, atrial tachycardia and nonsustained ventricular tachycardia.
By Thiru Gunasegaran | 05:40 am | May 31, 2021
The tech giant got both tools included in the Australian Register of Therapeutic Goods as Class IIa medical devices.
By Dave Muoio | 02:50 pm | February 01, 2021
The company hopes that its more descriptive reports will distinguish the personal ECG offering from others limited to atrial fibrillation detection alone.
By Dave Muoio | 03:40 pm | September 23, 2020
Also: European Commission pushes back Google-Fitbit antitrust investigation deadline; new handheld ultrasound devices.
By Tammy Lovell | 03:59 am | September 07, 2020
The wearable combines medical-grade ECG and sleep breathing disturbance detection.